Skip to main content
. 2021 Oct 29;14(11):1107. doi: 10.3390/ph14111107

Figure 1.

Figure 1

The summarized results of the mean value of SUVmax (lbm) in data sets from three acquisitions (T1—early 1.0–1.5h, T2—3.0–4.0 h and late T3—6.0–7.0 h) in selected patients with active disease including the mean value of SUVmax (lbm) for all detected and selected lesions (T1–T3_All), in those patients with the presence of prostate tumors (T1–T3_Tu) and in those subjects with metastatic disease including lymph nodes involvement and bone metastasis (T1–T3_Mts).